SCHEMBL4156047

SCHEMBL4156047

CNc1ccc([C]=O)c(NC)c1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 3/20 0.32
RECQL P46063 2/20 0.32
ALOX15 P16050 2/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
THRB P10828 1/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
HIF1A Q16665 1/20 0.32
APP P05067 1/20 0.31
TSHR P16473 2/20 0.31
EGFR P00533 2/20 0.31
MAPT P10636 1/20 0.31
HTT P42858 1/20 0.30
MEN1 O00255 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7232413 0.78 SLC22A12 (0.37) ALDH1A1HSD17B10RECQLALOX15CA12
SCHEMBL5537687 0.73 HTT (0.33) ALDH1A1HSD17B10RECQLALOX15CA12
SCHEMBL15795763 0.72 TSHR (0.39) ALDH1A1HSD17B10RECQLALOX15CA12
SCHEMBL27495712 0.71 HTR6 (0.32)
SCHEMBL244118 0.71 KDM4E (0.43) ALDH1A1HSD17B10RECQLHPGDTSHR
SCHEMBL7672004 0.71 MAPT (0.38) ALDH1A1HSD17B10RECQLCYP3A4THRB
SCHEMBL4094348 0.69 ALDH1A1 (0.50) ALDH1A1HSD17B10CA12CA1CA2
SCHEMBL1485842 0.69 MAPT (0.47) ALDH1A1RECQLCA12CA1CA2
SCHEMBL20860302 0.68 ADRA2A (0.32) APPTSHREGFR
SCHEMBL18500957 0.67 TSHR (0.35) ALDH1A1HSD17B10RECQLALOX15CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090068126-A1 Composition for surface photoprotection SOARES ROMEIRO LUIZ ANTONIO 2009-03-12 US claimed
EP-1812027-A2 COMPOUNDS CAPABLE OF ABSORBING ULTRAVIOLET RADIATION, COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION Universidade Federal Do Rio De Janeiro - UFRJ (BR) 2007-08-01 EP claimed
WO-2006042391-A2 PHOTOPROTECTIVE PHENOL DERIVATIVES OBTAINED FROM CASHEW NUT-SHELL LIQUID UNIVERSIDADE FEDERAL DO RIO DE JANEIRO-UFRJ (BR) 2006-04-27 WO claimed
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US claimed
EP-1001943-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP claimed
WO-1999003843-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO claimed
US-20090068126-A1 Composition for surface photoprotection SOARES ROMEIRO LUIZ ANTONIO 2009-03-12 US disclosed
EP-1812027-A2 COMPOUNDS CAPABLE OF ABSORBING ULTRAVIOLET RADIATION, COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION Universidade Federal Do Rio De Janeiro - UFRJ (BR) 2007-08-01 EP disclosed
WO-2006042391-A2 PHOTOPROTECTIVE PHENOL DERIVATIVES OBTAINED FROM CASHEW NUT-SHELL LIQUID UNIVERSIDADE FEDERAL DO RIO DE JANEIRO-UFRJ (BR) 2006-04-27 WO disclosed
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US disclosed
EP-1001943-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP disclosed
WO-1999003843-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068126-A1 Composition for surface photoprotection S100A10, CD63, S100A9 ALDH1A1 1804/4885HSD17B10 4053/4885RECQL 2154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.